Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

This study has been suspended.

( because in a preliminary analysis we would need 1000 patients per group to achieve significative differences in the main end point. )

Study NCT00287664 Information provided by Hospital Clinic of Barcelona

First Received: February 3, 2006 Last Updated: April 10, 2007 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Cirrhosis
Hepatorenal Syndrome

Additional conditions recognized in this trial

Fibrosis
Liver Cirrhosis
Syndrome

More general conditions related to this trial

Interventions listed in this trial

terlipressin

Additional drug interventions recognized in this trial

Lysine Vasopressin

More general drug interventions related to this trial

Sponsors listed in this trial